• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4635977)   Today's Articles (602)   Subscriber (50056)
For:  [Subscribe] [Scholar Register]
Number Cited by Other Article(s)
1
Qi JS, Su Q, Li T, Liu GW, Zhang YL, Guo JH, Wang ZJ, Wu MN. Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease. Neural Regen Res 2023;18:727-733. [DOI: 10.4103/1673-5374.353479] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
2
Alroughani RA, Ahmed SF, Khan RA, Al-Hashel JY. Spinal segmental myoclonus as an unusual presentation of multiple sclerosis. BMC Neurol 2015;15:15. [PMID: 25879483 PMCID: PMC4347575 DOI: 10.1186/s12883-015-0271-y] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2014] [Accepted: 02/18/2015] [Indexed: 11/10/2022]  Open
3
Antonen EG, Nikitina MV, Kruchek MM. Clinical experience of the use of agomelatine in the treatment of patients with depression and chronic brain ischemia. Zh Nevrol Psikhiatr Im S S Korsakova 2015;115:79-85. [DOI: 10.17116/jnevro201511511279-85] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA